Article
The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance.
Clinical endocrinology - 1 Sept 2012
Gois Miburge B, Salvatori Roberto, Aguiar-Oliveira Manuel H, Pereira Francisco A, Oliveira Carla R P, Oliveira-Neto Luiz A, Pereira Rossana M C, Souza Anita H O, Melo Enaldo V, de Paula Francisco J A
Abstract excerpt
OBJECTIVE: Growth hormone (GH)/insulin-like growth factor (IGF) axis and insulin are key determinants of bone remodelling. Homozygous mutations in the GH-releasing hormone receptor (GHRHR) gene (GHRHR) are a frequent cause of genetic isolated GH deficiency (IGHD). Heterozygosity for GHRHR mutation causes changes in body composition and possibly an increase in insulin sensitivity, but its effects on bone quality...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
